pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells
- PMID: 272640
- PMCID: PMC411225
- DOI: 10.1073/pnas.75.1.256
pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells
Abstract
A low molecular weight inhibitor of cell-free protein synthesis effective at subnanomolar concentrations is formed on incubation of cytoplasmic extracts from interferon-treated cells with double-stranded RNA and ATP. It can be conveniently synthesized by incubating a poly(I).poly(C)-Sepharose-bound enzyme fraction from such cells with [3H]- or [alpha- or gamma-32P]ATP. The radioactive inhibitor has been characterized by its behavior on DEAE-Sephadex in the presence of urea and on the basis of the products obtained on enzymic, alkaline, and sequential degradation by periodate oxidation and beta elimination. Its structure appears to be pppA2'p5'A2'p5'A. We have found no evidence for any modification or abnormality other than the 2'-5' linkage. On occasion the inhibitor preparations have included what seems to be the corresponding dimer (pppA2'p5'A), tetramer [ppp(A2'p)3A], pentamer [ppp(A2'p)4A], and higher oligomers in decreasing amounts. The trimer, tetramer, and pentamer are similar in activity, but the dimer is less potent if active at all.
Similar articles
-
Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells.Eur J Biochem. 1978 Mar;84(1):149-59. doi: 10.1111/j.1432-1033.1978.tb12151.x. Eur J Biochem. 1978. PMID: 206430
-
Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase.Eur J Biochem. 1984 Aug 15;143(1):165-74. doi: 10.1111/j.1432-1033.1984.tb08355.x. Eur J Biochem. 1984. PMID: 6088228
-
Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells.Eur J Biochem. 1978 Dec;92(2):455-62. doi: 10.1111/j.1432-1033.1978.tb12767.x. Eur J Biochem. 1978. PMID: 216547
-
Synthesis, characterization and properties of ppp(A2'p)nApCp and related high-specific-activity 32P-labelled derivatives of ppp(A2'p)nA.Eur J Biochem. 1981 Mar 16;115(1):79-85. doi: 10.1111/j.1432-1033.1981.tb06200.x. Eur J Biochem. 1981. PMID: 7227373
-
2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.Tex Rep Biol Med. 1981-1982;41:479-86. Tex Rep Biol Med. 1981. PMID: 6189212 Review. No abstract available.
Cited by
-
The intersection molecule MDA5 in Cancer and COVID-19.Front Immunol. 2022 Aug 31;13:963051. doi: 10.3389/fimmu.2022.963051. eCollection 2022. Front Immunol. 2022. PMID: 36119095 Free PMC article. Review.
-
Regulation of 2',5'-oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor.Mol Cell Biol. 1989 Mar;9(3):1060-8. doi: 10.1128/mcb.9.3.1060-1068.1989. Mol Cell Biol. 1989. PMID: 2542764 Free PMC article.
-
Chemical synthesis and biological activities of analogues of 2',5'-oligoadenylates containing 8-substituted adenosine derivatives.Nucleic Acids Res. 1990 Aug 11;18(15):4439-46. doi: 10.1093/nar/18.15.4439. Nucleic Acids Res. 1990. PMID: 2167468 Free PMC article.
-
Mechanism for discrimination between viral and host mRNA in interferon-treated cells.Proc Natl Acad Sci U S A. 1979 Jun;76(6):2600-4. doi: 10.1073/pnas.76.6.2600. Proc Natl Acad Sci U S A. 1979. PMID: 223150 Free PMC article.
-
Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.EMBO J. 2004 Oct 13;23(20):3929-38. doi: 10.1038/sj.emboj.7600420. Epub 2004 Sep 23. EMBO J. 2004. PMID: 15385955 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous